Effectiveness of the available COVID-19 primary and booster vaccination schemes against laboratory-confirmed infections during the different waves. by Rima Moghnieh (679199)

Subjects:

Effectiveness of the available COVID-19 primary and booster vaccination schemes against acute-care hospitalization attributed to laboratory-confirmed infections during the differen... by Rima Moghnieh (679199)

Subjects:

Themes derived from observations and focus group discussions. by Pallavi Oruganti (16024519)

Subjects:

A woman cooking in a home kitchen with typically-observed attire. by Pallavi Oruganti (16024519)

Subjects:

Immunogenicity assessment groups based on the primary and booster vaccination schemes and timeframe from the second or booster dose. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.4/BA.5 variant wave. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Alpha variant wave. by Rima Moghnieh (679199)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Omicron BA.1/BA.2 variant wave. by Rima Moghnieh (679199)

Subjects:

Map of study area. by Pallavi Oruganti (16024519)

Subjects:

Daily routines of women and men reported in focus groups respectively by gender. by Pallavi Oruganti (16024519)

Subjects:

Primary research objectives. by Pallavi Oruganti (16024519)

Subjects:

Fig 4 - by Rima Moghnieh (679199)

Subjects:

Demographics of focus group discussion participants. by Pallavi Oruganti (16024519)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the Delta variant wave. by Rima Moghnieh (679199)

Subjects:

Demographic summary from household observation participants (n = 12). by Pallavi Oruganti (16024519)

Subjects:

Demographic and clinical characteristics of the participants used to estimate effectiveness of the different vaccination schemes during the mixed Delta and Omicron variant wave. by Rima Moghnieh (679199)

Subjects:

COVID-19 in Lebanon: The daily number of COVID-19 cases throughout the waves of the pandemic in Lebanon and associated SARS-CoV-2 variants between January 2021 and September 2022. by Rima Moghnieh (679199)

Subjects:

Exposure pathways of priority zoonoses associated with acute febrile illness (leptospirosis, rickettsiosis, and Q fever) in the Mnisi community, Mpumalanga, South Africa. by Pallavi Oruganti (16024519)

Subjects:

Study profile. by Rima Moghnieh (679199)

Subjects:

Fig 3 - by Rima Moghnieh (679199)

Subjects: